BOLERO-2: Efficacy, safety, and quality of life in patients with advanced breast cancer receiving first-line everolimus plus exemestane Meeting Abstract


Authors: Campone, M.; Lebrun, F.; Neven, P.; Pistilli, B.; Rugo, H.; Baselga, J.; Brechenmacher, T.; Taran, T.; Sahmoud, T.; Hortobagyi, G.
Abstract Title: BOLERO-2: Efficacy, safety, and quality of life in patients with advanced breast cancer receiving first-line everolimus plus exemestane
Meeting Title: 17th European Cancer Conference (ECCO 17)
Journal Title: European Journal of Cancer
Volume: 49
Issue: Suppl. 2
Meeting Dates: 2013 Sep 27-Oct 1
Meeting Location: Amsterdam, Netherlands
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2013-09-01
Start Page: S419
End Page: S420
Language: English
ACCESSION: WOS:000326843603008
PROVIDER: wos
DOI: 10.1016/S0959-8049(13)70062-5
Notes: Meeting Abstract: 1912 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga